RPRX- Royalty Pharma Plc

Name: Royalty Pharma Plc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Legorreta Pablo G.	941.0K	$47.79M	-
VP	Hite Christopher	658.5K	$33.45M	-
Dir	Norden Gregory	194.8K	$9.90M	-
Dir	Desouza Errol B	81.4K	$4.13M	-
?	Bassler Bonnie L	73.1K	$3.71M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 7, 2021	Urist Marshall73	EVP &Co-head Of R&I	Sell	33,134	$46.08	$1,526,720.52	-66.7%	-15.7%	-9.5%
Jun 2, 2021	Urist Marshall73	EVP &Co-head Research &Inv.	Sell	14,566	$41.52	$604,850.24	-30.5%	-9.7%	-3.9%
Jun 2, 2021	Reddoch James F.66	EVP, Research &Investments	Sell	50,000	$42.13	$2,106,560.00	-3.3%	-9.7%	-3.9%
Jun 2, 2021	Lloyd George W.71	EVP, Investments &GC	Sell	62,500	$42.12	$2,632,512.50	-3.4%	-9.7%	-3.9%
May 21, 2021	Urist Marshall73	EVP &Co-head Research &Inv.	Sell	2,000	$41.08	$82,159.03	-2.1%	-4.1%	-1.2%
Apr 14, 2021	Lloyd George W.71	EVP, Investments &GC	Sell	69,822	$42.13	$2,941,920.15	-21.8%	-0.4%	+6.5%
Apr 14, 2021	Reddoch James F.66	EVP, Research &Investments	Sell	55,714	$42.10	$2,345,592.83	-21.8%	-0.4%	+6.5%
Apr 12, 2021	Lloyd George W.71	EVP, Investments &GC	Sell	449	$42.32	$19,001.68	-0.1%	+1.6%	+3.2%
Apr 12, 2021	Reddoch James F.66	EVP, Research &Investments	Sell	359	$42.32	$15,192.88	-0.1%	+1.6%	+3.2%
Mar 22, 2021	Lloyd George W.71	EVP, Investments &GC	Sell	54,729	$46.32	$2,535,226.28	-8.7%	-5.8%	-14.1%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC